| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/29/1996 | CA2198011A1 Methods of reducing scarring in wound healing |
| 02/29/1996 | CA2188948A1 Device for delivery of substances and methods of use thereof |
| 02/28/1996 | EP0697885A1 Insulin-like growth factor ii as antitumour agent |
| 02/28/1996 | EP0697880A1 Inhibition of leukocyte adhesion |
| 02/28/1996 | EP0697868A1 Methods and compositions using optically pure (+)-zileuton |
| 02/28/1996 | EP0697851A1 Composition for the treatment of impaired hair growth |
| 02/28/1996 | CN1117712A Extract from flowers of salvia officinalis, process for its preparation and use thereof |
| 02/28/1996 | CN1117396A Medicine for treating burns |
| 02/27/1996 | US5495043 Substituted di-t-butylphenols |
| 02/27/1996 | US5495021 Benzo[f]quinolinones |
| 02/27/1996 | US5494924 Therapeutical method for the treatment of dermatoses using O-esters of L-carnitine |
| 02/27/1996 | US5494907 11-β substituted-19-nor steroids |
| 02/27/1996 | US5494906 Treating metabolic bone disease |
| 02/27/1996 | CA2155447A1 Substituted biphenyl isoxazole sulfonamides |
| 02/27/1996 | CA1338083C Ozonides of terpenes and their medical uses |
| 02/22/1996 | WO1996005297A1 Method of gene therapy using dna vectors without selection marker gene |
| 02/22/1996 | WO1996005165A1 Retinoic acid x-receptor ligands |
| 02/22/1996 | WO1996004894A1 Anti-acne cosmetic compositions |
| 02/22/1996 | CA2196982A1 Anti-acne cosmetic compositions |
| 02/21/1996 | EP0697397A1 L-carnitine salt and compositions containing same |
| 02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
| 02/21/1996 | CN1116924A Utilisation des acides sulfoniques comme agents antivieillissement dans une composition cosmetiqueou dermatologique |
| 02/20/1996 | US5493030 5-substituted derivatives of mycophenolic acid |
| 02/20/1996 | CA1338077C Heterodimeric transforming growth factor-beta |
| 02/17/1996 | CA2156197A1 Composition and subcompositions of same: process for obtaining them and their molecular identification, and their anti-inflammatory, analgesic, antipruritic and local antipyretic therapeutic effect in human beings and animals |
| 02/15/1996 | WO1996004280A1 Phenyl xanthine derivatives |
| 02/15/1996 | WO1996003983A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 02/15/1996 | WO1995031991A3 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 02/15/1996 | DE4428402A1 Gentherapeutisches Verfahren unter Verwendung von DNA-Vektoren ohne Selektionsmarker-Gen Gene therapy methods using DNA vectors without selectable marker gene |
| 02/15/1996 | CA2196701A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 02/14/1996 | EP0696598A1 Polysaccharide esters and their salts |
| 02/14/1996 | EP0696321A1 Macrophage inflammatory protein variants |
| 02/14/1996 | EP0696312A1 Process for obtaining high-purity egg oil and use thereof |
| 02/14/1996 | EP0696275A1 Vitamin d amide derivatives |
| 02/14/1996 | EP0696203A1 Use of ceruletide diethyl amine salt in the treatment of psoriasis |
| 02/14/1996 | EP0696201A1 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 02/14/1996 | CN1116823A Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 02/14/1996 | CN1116520A Skin protecting composition containing acid hydrophilic agent for cosmetic use and application of same |
| 02/13/1996 | US5491128 Aglycons of A/16686 antibiotics |
| 02/08/1996 | WO1996003437A1 PTH OR PTHrP ANTAGONISTS |
| 02/08/1996 | WO1996003430A1 Organic compounds |
| 02/08/1996 | WO1996003407A1 Compounds useful as antiproliferative agents and garft inhibitors |
| 02/08/1996 | WO1996003399A1 Dihydrobenzofuranes |
| 02/08/1996 | WO1996003396A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 02/08/1996 | WO1996003149A1 Antifungal-wound healing compositions and methods for preparing and using same |
| 02/08/1996 | WO1996003129A1 Method of treating sweat-related conditions |
| 02/08/1996 | WO1996003110A1 Lipophilic hydroxylated acid, cosmetic and pharmaceutical use thereof and method for preparing same |
| 02/08/1996 | WO1996003033A2 Use of a commiphora mukul extract as a pigmenting agent |
| 02/08/1996 | CA2195673A1 Use of a commiphora mukul extract as a pigmenting agent |
| 02/08/1996 | CA2193852A1 Method of treating sweat-related conditions |
| 02/08/1996 | CA2192787A1 Pth or pthrp antagonists |
| 02/08/1996 | CA2191603A1 Antifungal-wound healing compositions and methods for preparing and using same |
| 02/07/1996 | EP0695181A1 Methods of using hesperetin for sebum control and treatment of acne |
| 02/06/1996 | US5489615 Pharmaceutical ointment being free from skin irritative action and a process for the preparation thereof |
| 02/01/1996 | WO1996002555A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | WO1996002507A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis |
| 02/01/1996 | WO1996002497A1 Substituted benzamidines, their production and their use as medicaments |
| 02/01/1996 | WO1996002496A1 Novel chemical compound, its preparation and use as a drug |
| 02/01/1996 | WO1996002488A1 Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics |
| 02/01/1996 | WO1996002267A1 Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 02/01/1996 | WO1996002260A1 Wound healing agent |
| 02/01/1996 | WO1996002258A1 Anti-adhesion agent |
| 02/01/1996 | WO1996002257A1 Antisense oligonucleotides of pleiotrophin |
| 02/01/1996 | WO1996002233A1 Immunological activity of rhamnolipids |
| 02/01/1996 | WO1996002229A2 Soap composition |
| 02/01/1996 | CA2560114A1 Immunomodulatory oligonucleotides |
| 02/01/1996 | CA2195450A1 Antisense oligonucleotides of pleiotrophin |
| 02/01/1996 | CA2194886A1 Novel chemical compound, its preparation and use as a drug |
| 02/01/1996 | CA2191975A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis |
| 01/31/1996 | EP0694307A1 Atopic disease remedy |
| 01/31/1996 | EP0694305A1 Pharmaceutical or cosmetic formulations containing coumarins and proanthocyanidinis |
| 01/31/1996 | EP0693933A1 Methods and compositions for delaying or preventing the onset of autoimmune disease |
| 01/31/1996 | EP0608353B1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
| 01/31/1996 | EP0606197B1 Use of aromatic benzoates as personal deodorants |
| 01/31/1996 | EP0593615B1 Aromatic compounds, compositions containing them and their use in therapy |
| 01/31/1996 | CN1115982A Pharmacologically active pyridine derivatives and processes for the preparation thereof |
| 01/31/1996 | CN1115980A Dehydrogenation process |
| 01/31/1996 | CN1115979A New crystalline form of vitamin D analogue |
| 01/31/1996 | CN1115662A Drug for acne and its prepn |
| 01/30/1996 | US5488135 Bis(phenyl)ethane derivatives |
| 01/30/1996 | US5487884 Photoprotection compositions comprising chelating agents |
| 01/30/1996 | CA1338008C Transdermal flux enhancing compositions |
| 01/25/1996 | WO1996001896A1 Connective tissue growth factor-2 |
| 01/25/1996 | WO1996001653A1 Methods and compositions for the specific coagulation of vasculature |
| 01/25/1996 | WO1996001648A1 Attenuation of wound healing processes |
| 01/25/1996 | WO1996001646A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | WO1996001645A1 Use of muramyl peptide compounds |
| 01/25/1996 | WO1996001636A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | WO1996001633A1 New formulation for the topical treatment of psoriasis |
| 01/25/1996 | WO1996001632A1 Method and compound for the treatment of hair loss |
| 01/25/1996 | WO1996001618A1 Dermatologic preparation |
| 01/25/1996 | CA2194773A1 Method and compound for the treatment of hair loss |
| 01/25/1996 | CA2194678A1 Use of muramyl peptide compounds |
| 01/25/1996 | CA2194550A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | CA2194366A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/24/1996 | EP0693278A2 Combinations of vasoactive substances with fatty acids to prevent hair loss |
| 01/24/1996 | EP0692968A1 Urokinase plasminogen activator fragments |
| 01/24/1996 | EP0692931A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
| 01/23/1996 | US5486624 Free radical scavengers, tyrosinase inhibitors |
| 01/23/1996 | US5486525 Platelet activating factor antagonists: imidazopyridine indoles |